Of the most senior full time jobs on the career ladder to chief executive, such as divisional or regional heads, only 21% are ...
Mississauga: GSK has announced that Health Canada has approved Ojjaara ... prognosis and survival for anemic myelofibrosis ...
GSK announced that Health Canada has approved Ojjaara (momelotinib ... prognosis and survival for anaemic myelofibrosis patients,” said Cheryl Petruk, CEO of HEAL Canada. “We are excited to witness ...
As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...
GSK added Ojjaara to its portfolio through the acquisition of Sierra in 2022. Credit: Magda Wygralak via Shutterstock. Health ...
Flagship Pioneering, the bioplatform innovation company, and Apriori Bio, a biotechnology company aimed at providing humanity with variant-resilient protection against rapidly-evolving viruses, today ...